---
title: Newsroom | Drug Discovery & Development (3)
description: Drug Discovery & Development |  (3)
---

[![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/)

- [Newsroom](https://news.lifesciencenewswire.com/newsroom)
- [Back to the main site](https://lifesciencenewswire.com/)

![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1")

# Newsroom

#### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow")

#### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg)

![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg)

### Choose a Category

- [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture)
- [AI (3)](https://news.lifesciencenewswire.com/newsroom/tag/ai)
- [Analytical Chemistry (43)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry)
- [Biomanufacturing (37)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing)
- [biopharma (24)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)
- [Bioprocessing (17)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing)
- [Biotechnology (256)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology)
- [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture)
- [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)
- [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)
- [Clinical Research & Trials (118)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)
- [Computing & Technology (63)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it)
- [Conferences & Events (1)](https://news.lifesciencenewswire.com/newsroom/tag/conferences-events)
- [Corporate, Finance & Investor (290)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)
- [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)
- [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory)
- [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology)
- [Drug Discovery & Development (156)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)
- [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment)
- [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients)
- [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage)
- [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry)
- [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory)
- [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science)
- [Healthcare (138)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare)
- [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)
- [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science)
- [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing)
- [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science)
- [Medical Devices & Technology (28)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)
- [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)
- [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging)
- [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech)
- [Omics & Genetics (90)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics)
- [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology)
- [Pharma (119)](https://news.lifesciencenewswire.com/newsroom/tag/pharma)
- [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy)
- [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research)
- [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary)
- [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water)

See all

### Subscribe to Email Updates

<https://news.lifesciencenewswire.com/newsroom/alithea-genomics-introduces-mercurius-spheroid-drug-seq-extraction-free-rna-seq-for-3d-drug-screening-and-toxicology>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)

#### [Alithea Genomics introduces MERCURIUS™ Spheroid DRUG-seq: extraction-free, RNA-seq for 3D drug screening and toxicology](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-introduces-mercurius-spheroid-drug-seq-extraction-free-rna-seq-for-3d-drug-screening-and-toxicology)

 October 9, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-introduces-mercurius-spheroid-drug-seq-extraction-free-rna-seq-for-3d-drug-screening-and-toxicology)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-introduces-mercurius-spheroid-drug-seq-extraction-free-rna-seq-for-3d-drug-screening-and-toxicology#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 9, 2025, 12:00:02 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-launches-cellartis-msc-ev-wonder-a-defined-xeno-free-medium-for-high-yield-ev-production>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma)

#### [Takara Bio Europe launches Cellartis® MSC EV Wonder™, a defined, xeno-free medium for high-yield EV production](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-launches-cellartis-msc-ev-wonder-a-defined-xeno-free-medium-for-high-yield-ev-production)

 September 24, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-launches-cellartis-msc-ev-wonder-a-defined-xeno-free-medium-for-high-yield-ev-production)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-launches-cellartis-msc-ev-wonder-a-defined-xeno-free-medium-for-high-yield-ev-production#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 24, 2025, 11:59:59 AM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/epicypher-launches-fiber-seq-a-breakthrough-multiomic-single-molecule-genomics-assay>

 Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)

#### [EpiCypher launches Fiber-seq, a breakthrough multiomic single-molecule genomics assay](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-fiber-seq-a-breakthrough-multiomic-single-molecule-genomics-assay)

 September 3, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-fiber-seq-a-breakthrough-multiomic-single-molecule-genomics-assay)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-fiber-seq-a-breakthrough-multiomic-single-molecule-genomics-assay#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 3, 2025, 3:15:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/aptamer-group-introduces-novel-biomarker-discovery-service>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [Aptamer Group introduces novel biomarker discovery service](https://news.lifesciencenewswire.com/newsroom/aptamer-group-introduces-novel-biomarker-discovery-service)

 August 28, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/aptamer-group-introduces-novel-biomarker-discovery-service)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/aptamer-group-introduces-novel-biomarker-discovery-service#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 28, 2025, 12:15:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/gennext-technologies-and-thermo-fisher-scientific-collaborate-to-simplify-structural-biology-for-faster-biotherapeutic-development>

 Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [GenNext Technologies and Thermo Fisher Scientific collaborate to simplify structural biology for faster biotherapeutic development](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-and-thermo-fisher-scientific-collaborate-to-simplify-structural-biology-for-faster-biotherapeutic-development)

 May 7, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-and-thermo-fisher-scientific-collaborate-to-simplify-structural-biology-for-faster-biotherapeutic-development)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/gennext-technologies-and-thermo-fisher-scientific-collaborate-to-simplify-structural-biology-for-faster-biotherapeutic-development#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 7, 2025, 12:30:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery>

 Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)

#### [EpiCypher launches novel, affordable DNA methylation sequencing assays to accelerate drug discovery](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery)

 April 24, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/epicypher-launches-novel-affordable-dna-methylation-sequencing-assays-to-accelerate-drug-discovery#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 24, 2025, 5:11:09 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/indivumed-celebrates-milestone-of-its-patient-centric-rd-platform-numerous-novel-cancer-targets-discovered-for-first-in-class-therapeutics>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Indivumed celebrates milestone of its patient-centric R&D platform: Numerous novel cancer targets discovered for first-in-class therapeutics](https://news.lifesciencenewswire.com/newsroom/indivumed-celebrates-milestone-of-its-patient-centric-rd-platform-numerous-novel-cancer-targets-discovered-for-first-in-class-therapeutics)

 April 8, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/indivumed-celebrates-milestone-of-its-patient-centric-rd-platform-numerous-novel-cancer-targets-discovered-for-first-in-class-therapeutics)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/indivumed-celebrates-milestone-of-its-patient-centric-rd-platform-numerous-novel-cancer-targets-discovered-for-first-in-class-therapeutics#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Apr 8, 2025, 12:00:00 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962>

 Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)

#### [Leica Biosystems and Indica Labs announce significant strategic investment and creation of digital pathology platform](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962)

 January 8, 2025

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 8, 2025, 1:13:03 PM

- [Tweet](https://twitter.com/share)

<https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition-of-cro-alderley-analytical>

 Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)

#### [Synexa Life Sciences expands bioanalysis capabilities with the acquisition of CRO Alderley Analytical](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition-of-cro-alderley-analytical)

 October 7, 2024

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition-of-cro-alderley-analytical)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition-of-cro-alderley-analytical#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 7, 2024, 9:00:00 AM

- [Tweet](https://twitter.com/share)

[Previous](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/2) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development/page/4)

##### Browse more news

## Recent releases

<https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr>

#### [Alyssum Therapeutics Presents Phase 1 Results for First-in-Class CMTR2 Inhibitor AT-1965 at EORTC-NC...](https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr)

 November 19, 2026

Alyssum Therapeutics Inc., a clinical stage biopharmaceutical company developing a pipeline of first in class therapeutics through a patented technolo...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr)

<https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026>

#### [Sciensus Nurses to Present Data on Scalp Cooling Access, Virtual Peer Support and Post-Incident Clin...](https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026)

 November 11, 2026

Sciensus, a leading European life sciences organisation focused on accelerating patients' access to life-saving medicines, will present three posters ...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026)

<https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency>

#### [Biognosys Launches Industrialized Discovery to Deliver Scalable, AI-ready Proteomics with Exceptiona...](https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency)

 November 10, 2026

AI-ready data by design: Standardized, quality-controlled and reproducible quantitative proteomics data, built for integration into large-scale and AI...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency)

![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse")

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225 

#### Useful information

- [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/)
- [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions)
- [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)